H. Dawn Fukuda
Dawn Fukuda has been working in HIV/AIDS services in the U.S. and Massachusetts for the past twenty years. Her professional experience includes positions as an HIV/AIDS case manager, researcher, community health educator, medical advocate, and professional trainer. For the past nine years she has worked at the Massachusetts Department of Public, Health Office of HIV/AIDS, as both a contract manager and the Associate Director of Health Services. For the past three years, Dawn has served as the Director of the Office of HIV/AIDS (OHA) and State HIV/AIDS Director for the Commonwealth of Massachusetts. She represents Massachusetts as a member of the National Association of State and Territorial AIDS Directors (NASTAD), and currently serves as the Chair of the National Alliance. She has recently been appointed by the Secretary Kathleen Sebelius of the Department of Health and Human Services to serve as a member of the CDC and HRSA Advisory Committee on HIV, STIs, and Viral Hepatitis (or the CHAC). Dawn has focused her studies in the areas of public health program planning, health promotion, and program evaluation. Her areas of expertise include HIV/AIDS and substance use, medical advocacy, and communication in health care settings. She holds a Bachelor of Arts (B.A.) degree from The Johns Hopkins University and a Master of Science degree in Public Health (Sc.M.) from Harvard University.

For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































